The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: Study protocol for a randomized controlled trial
10.1186/s13063-015-0651-z
Saved in:
Main Authors: | Low J.G., Wijaya L., Li G.K.Y., Lim E.Y.L., Shum A.K.L., Cheung Y.-B., Ooi E.-E. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/144304 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
by: Murray S.M.
Published: (2023) -
Short report: Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel
by: Sathit Pichyangkul, et al.
Published: (2018) -
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
by: Budigi Y., et al.
Published: (2020) -
Sequential Vaccination With Heterologous Acinetobacter baumannii Strains Induces Broadly Reactive Antibody Responses
by: Gathoni Kamuyu, et al.
Published: (2022) -
Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse
by: Naphak Modhiran, et al.
Published: (2018)